Ativo Circulante Alterar Data
Abbott USD 23.5B 1.02B 2026-09
Accuray USD 292.39M 11.22M 2025-12
AngioDynamics USD 161.35M 4.69M 2025-09
Artivion USD 371.38M 13.86M 2026-06
AtriCure USD 363.39M 17.86M 2026-09
Boston Scientific USD 8.16B 192M 2026-09
Edwards Lifesciences USD 7.25B 428.6M 2026-09
Inogen USD 203.72M 594K 2025-09
Mesa Laboratories USD 105.63M 8.2M 2025-12
Orthofix International USD 446.13M 15.39M 2026-06
Tandem Diabetes Care USD 804.64M 82.46M 2026-06
Trinity Biotech USD 31.36M 4.54M 2026-03